https://www.selleckchem.com/pr....oducts/lusutrombopag
001). We observed no significant difference in NFI and MBS between arms (p= 0.282, 0.182). We found no significant changes in FSFI, NFI, and MBS, but significant improvement in vaginal pH and VMV in postmenopausal women with FSD treated with vaginally administered conjugated estrogens tablet. Few side-effects were reported. Thai Clinical Trial Registry identification number TCTR20180219001 , prospectively registered since 2018-02-19 113321. Thai Clinical Trial Registry identification number TCTR20180219001 , prospectively register
Like
Comment
Share
